Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upgrading its current co-marketing ...

The primary outcome measure in PUNCH CD 3 is the proportion of patients with recurrent C. diff infection within eight weeks of starting treatment with either RBX2660 or placebo. Patients will be ...

Expert Rev Anti Infect Ther. 2010;8(10):1113-1119.

The study, published Sept. 30 in Open Forum Infectious Diseases, analyzed 45,049 patient records from 779 hospitals of adults who received treatment for C. diff infections before and after 2021.

The use of fidaxomicin for Clostridioides difficile infection (CDI) has increased significantly since 2021 but it ... which is the most common healthcare-associated infection in adults and affects an ...

French envoy Thierry Mathou informed that an important education fair will take place mid-October to present all the opportunities to students. Details below.

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...

The IBD center is the only children’s clinic in Maryland that has a focus on very early onset-IBD and it was among the first to perform fecal microbiota transplantations for children with IBD who have ...

WinMerge is an Open Source differencing and merging tool for Windows. WinMerge can compare both folders and files, presenting differences in a visual text format that is easy to understand and handle.

Nurses and nurse midwives have historically considered patient education one of their most important responsibilities. Increasingly, however, appropriate and comprehensive patient education has ...